In an animal model of AD, the inhibition of MAGL activity suppressed the expression and activity of BACE1 and the accumulation of Aβ, reduced inflammation and neurodegeneration, and improved long-term synaptic plasticity and cognitive abilities [139]. This evidence concerns the gene MGLL and Alzheimer disease.